Results 31 to 40 of about 3,398,816 (318)

Cost-effectiveness of expanding the target population of biennial screening for breast cancer from ages 50–69 to 45 and/or 74: A cohort modelling study in the Finnish setting

Health Economics Review
Background Within Finland’s breast cancer screening program, all women aged 50–69 are invited to biennial screening. Current European guidelines recommend screening in ages 45–49 and 70–74 conditional upon, inter alia, demonstrated context-specific cost ...
Filip Siegfrids, Sirpa Heinävaara, Tytti Sarkeala, Laura Niinikoski, Juha Laine   +4 more
doaj   +1 more source

The cancer registry as a cancer‐control tool [PDF]

Cancer, 2016
Today's cancer registry is a powerful public health and cancer control tool. Assessment can provide insight into practice patterns and the effectiveness of interventions. The future of the cancer registry involves acquisition of big data from the electronic medical record.
openaire   +2 more sources

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine, Hallie Coltin, Sylvia Cheng, Lucie Lafay‐Cousin, Vanan Issai Magimairajan, Craig Erker, Stéphanie Vairy, Lynette Bowes, Adam Fleming, Donna Johnston, Sarah McKillop, Roona Sinha, Julie Bennett, Christina Coleman, Laura Wheaton, Shayna Zelcer, Samuele Renzi, Thai Hoa Tran   +17 more
wiley   +1 more source

Semi-automated monitoring of deviations from historical incidence trends for enhanced timeliness in cancer control

ESMO Real World Data and Digital Oncology
Background: Population-based cancer registries aim for timely reporting of cancer incidence and rapid identification of unexpected patterns to support cancer control.
H.M. Peacock, T. Locus, G. Silversmit, B. Van Gool, K. Van Herck, L. Van Eycken, H. De Schutter   +6 more
doaj   +1 more source

Socioeconomic inequalities in cancer incidence in Europe: a comprehensive review of population-based epidemiological studies

Radiology and Oncology, 2020
Since the end of the previous century, there has not been a comprehensive review of European studies on socioeconomic inequality in cancer incidence.
Mihor Ana, Tomsic Sonja, Zagar Tina, Lokar Katarina, Zadnik Vesna   +4 more
doaj   +1 more source

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

Pediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz, Se Whee Sammy Park, Aironas Los, Ernest Liu, Nona Struyf, Tom Erkers, Sören Lehmann, Jan J. Molenaar, Jakob Stenman, Olli Kallioniemi, Päivi Östling, Brinton Seashore‐Ludlow, Kasper Karlsson   +12 more
wiley   +1 more source

Evaluating incidence and mortality trends of early-onset colorectal cancer and adenoma in Belgium

ESMO Gastrointestinal Oncology
Background: Colorectal cancer (CRC) incidence is rising among young adults globally, yet European data remain inconclusive. This study evaluated age- and sex-specific trends in CRC incidence, adenoma detection, and mortality in Belgium, with a focus on ...
S. Janssens, K. Van Herck, J. Francart, B. Van Gool, A. Audibert, C. Clinckaert, N. Van Damme, K. Haustermans, L. Van Eycken   +8 more
doaj   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani, Rachel K. Peterson, Avani D. Rao, Laurie J. McKenzie, Ahmed Magdy Elmotayam, Leslie Chang, Michael Roth, Susan L. McGovern   +7 more
wiley   +1 more source

Sixty years of population-based survival monitoring in childhood and adolescent cancer: evidence from Slovenia

Frontiers in Cancer Control and Society
BackgroundLong-term survival of children and adolescents (CA) diagnosed with cancer has hardly been researched in Slovenia. Our aim was to present the survival trend at the population level over a period of 60 years with an additional comparison between ...
Tina Žagar, Mojca Birk, Ana Mihor, Maja Jurtela, Urška Tomšič, Urška Tomšič, Katarina Lokar, Teja Oblak, Nika Bric, Sonja Tomšič, Miran Mlakar, Vesna Zadnik   +11 more
doaj   +1 more source

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben, Marisa H. Huisman, Martha A. Grootenhuis, Femke K. Aarsen, Marita Partanen   +4 more
wiley   +1 more source